The specific knockout of Reg3b or administration of anti-Reg1, anti-Reg3a, and anti-Reg4 antibodies worsen experimental pancreatitis, while administration of recombinant Reg3a and Reg4 can significantly reduce the pancreatic damage10–13. This evidence concerns the gene REG3A and pancreatitis.